Utah Medical Products (UTMD) Gross Profit (2016 - 2025)
Utah Medical Products has reported Gross Profit over the past 16 years, most recently at $5.3 million for Q4 2025.
- Quarterly results put Gross Profit at $5.3 million for Q4 2025, down 1.11% from a year ago — trailing twelve months through Dec 2025 was $22.0 million (down 8.88% YoY), and the annual figure for FY2025 was $22.0 million, down 8.87%.
- Gross Profit for Q4 2025 was $5.3 million at Utah Medical Products, down from $5.6 million in the prior quarter.
- Over the last five years, Gross Profit for UTMD hit a ceiling of $8.3 million in Q4 2022 and a floor of $5.3 million in Q4 2025.
- Median Gross Profit over the past 5 years was $7.2 million (2023), compared with a mean of $7.0 million.
- Biggest five-year swings in Gross Profit: surged 57.27% in 2021 and later fell 25.01% in 2024.
- Utah Medical Products' Gross Profit stood at $8.1 million in 2021, then rose by 2.65% to $8.3 million in 2022, then fell by 14.76% to $7.1 million in 2023, then fell by 25.01% to $5.3 million in 2024, then decreased by 1.11% to $5.3 million in 2025.
- The last three reported values for Gross Profit were $5.3 million (Q4 2025), $5.6 million (Q3 2025), and $5.6 million (Q2 2025) per Business Quant data.